Titan Pharmaceuticals Inc Capital Reinvestment Ratio
Titan Pharmaceuticals Inc capital reinvestment ratio. Titan Pharmaceuticals Inc (TTNP) has a Capital Reinvestment Ratio of 0.00x as of June 2016, meaning it reinvests 0% of its operating cash flow ($13.51 Million) in capital expenditures ($9.00K). Check TTNP cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Titan Pharmaceuticals Inc (1997–2016)
Capital reinvestment ratio of Titan Pharmaceuticals Inc from 1997 to 2016. This chart tracks Titan Pharmaceuticals Inc's Capital Reinvestment Ratio across 3 annual periods. Also explore TTNP net assets growth trend to track the company's year-over-year net asset growth rate.
Titan Pharmaceuticals Inc Capital Reinvestment Ratio by Year (1997–2016)
Titan Pharmaceuticals Inc capital reinvestment ratio by year from 1997 to 2016. For the full cash flow conversion analysis, see Titan Pharmaceuticals Inc cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.03x | $6.29 Million | $171.00K | ▼ -95.7% |
| 2012 | 0.63x | $1.83 Million | $1.15 Million | ▲ +4377.3% |
| 1997 | 0.01x | $7.10 Million | $100.00K | — |